| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $42.73M | $108.30M | $113.31M | $3.65M | $40.96M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $258.11M | $218.71M | $181.30M | $166.37M | $167.98M |
| R&D | $182.78M | $159.68M | $130.01M | $115.86M | $121.88M |
| SG&A | $75.33M | $59.02M | $51.29M | $50.51M | $46.10M |
| Operating Income | -$215.38M | -$110.40M | -$68.00M | -$162.72M | -$127.02M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | -$677.00K | $681.00K | -$204.00K |
| Net Income | -$204.38M | -$97.01M | -$57.51M | -$161.82M | -$122.25M |
| EPS (basic) | -1.2100 | -0.7000 | -0.5400 | -2.0500 | -2.3600 |
| EPS (diluted) | -1.2100 | -0.7000 | -0.5400 | -2.0500 | -2.3600 |
| Shares (diluted) | $168.65M | $138.28M | $106.10M | $78.86M | $51.83M |